The connection between emotional and physical pain

What happens when emotional pain becomes physical? Dr Anchita Karmakar and clinical pharmacist and PainWISE Director Joyce McSwan explore this concept. When Dr Karmakar lost...

Environmentally responsible inhaled respiratory treatments – Implications for practice

Ziqi is a regular at your pharmacy. She has popped in today to purchase a salbutamol pressurised metered dose inhaler (pMDI). You notice on her dispensing history that this will be her third in the last 4 weeks and she is overdue to have her repeat for her budesonide dry powder inhaler (DPI) filled.

Medication management in older Australians

A national pharmacy-led working group dedicated to improving the quality use of medicines for older Australians has issued 10 recommendations for better integrating healthcare...

Weighing up the options

A flood of weight loss injectables is on its way, which may aid pharmacists in helping to stem the obesity crisis.

The therapeutic potential of psychedelics

Thom, 37, a regular patient of the pharmacy, presents their venlafaxine repeat for dispensing. You know this has been prescribed for PTSD and ask how they have been going with their treatment. They disclose that their symptoms have been difficult to manage over the last few weeks and that they don’t feel like their medication has been working as well. Thom explains that a friend mentioned MDMA could be used for PTSD, and they’re now considering taking it to help them feel better.

Why all patients should be using a spacer

Questions about spacers are abundant in community pharmacy. AP answers some of the trickiest ones pharmacists face.